scispace - formally typeset
Open AccessJournal ArticleDOI

Immunology of COVID-19: Current State of the Science.

Nicolas Vabret, +87 more
- 16 Jun 2020 - 
- Vol. 52, Iss: 6, pp 910-941
Reads0
Chats0
TLDR
The current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death are summarized.
About
This article is published in Immunity.The article was published on 2020-06-16 and is currently open access. It has received 1350 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review

TL;DR: The current coronavirus disease 2019 (COVID-19) pandemic is caused by the newest SARS virus, SARS-CoV-2, an enveloped, positive-sense, single-stranded RNA betacoronavirus of the family Coronaviridae as mentioned in this paper.
Journal ArticleDOI

Korean traditional foods as antiviral and respiratory disease prevention and treatments: A detailed review.

TL;DR: Kim et al. as discussed by the authors reviewed the information available on edible plants, herbs, mushrooms, and preparations used in Korean traditional food to outline their multiple medicinal effects (e.g., antidiabetic, chemopreventive, antioxidative, anti-inflammatory, antibacterial), emphasizing their role and effects on the immune system with an emphasis on modulating properties of the gut microbiota that further support strong respiratory immunity.
Journal ArticleDOI

Animal Models of COVID-19 II. Comparative Immunology.

TL;DR: In this paper, the authors discuss both small and large animal model studies previously used in SARS-CoV-2 research that may be useful in elucidating the immunological contributions to hallmark syndromes observed with COVID-19.
Journal ArticleDOI

Current Progress and Challenges in the Design and Development of a Successful COVID-19 Vaccine

TL;DR: An overview of the COVID-19 vaccine candidates currently in development can be found in this article, where the authors discuss the scientific and practical challenges associated with vaccine design, and share the potential strategies that could be exploited for vaccine design success.
Journal ArticleDOI

Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19.

TL;DR: A host-directed approach uses a perturbation profiles of ∼3,000 small molecules with a high-quality signature of IFN-β-responsive genes in primary normal human bronchial epithelial cells to identify four candidate COVID-19 compounds, namely homoharringtonine, narciclasine, anisomycin, and emetine.
References
More filters
Journal ArticleDOI

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

TL;DR: The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described.
Journal ArticleDOI

COVID-19: consider cytokine storm syndromes and immunosuppression

TL;DR: Re-analysis of data from a phase 3 randomised controlled trial of IL-1 blockade (anakinra) in sepsis, showed significant survival benefit in patients with hyperinflammation, without increased adverse events.
Related Papers (5)